IO Biotech Files 8-K with Corporate Updates
Ticker: IOBT · Form: 8-K · Filed: Nov 18, 2025 · CIK: 1865494
| Field | Detail |
|---|---|
| Company | Io Biotech, Inc. (IOBT) |
| Form Type | 8-K |
| Filed Date | Nov 18, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-disclosure, filing
TL;DR
IO Biotech filed an 8-K on 11/18/25 with corporate info and exhibits.
AI Summary
IO Biotech, Inc. filed an 8-K on November 18, 2025, reporting on events that require disclosure under Regulation FD and including financial statements and exhibits. The filing details the company's corporate information, including its state of incorporation (Delaware), fiscal year end (December 31), and principal executive offices located in Copenhagen, Denmark.
Why It Matters
This 8-K filing provides essential corporate information and disclosures for IO Biotech, Inc., which is crucial for investors and stakeholders to stay informed about the company's status and regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new financial or operational risks.
Key Numbers
- 001-41008 — Commission File Number (Identifies the company's filing with the SEC.)
- 87-0909276 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- IO Biotech, Inc. (company) — Registrant
- November 18, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- Copenhagen, Denmark (location) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose is to report under Regulation FD and to include financial statements and exhibits as required.
When was this 8-K report filed?
The report was filed on November 18, 2025.
Where are IO Biotech, Inc.'s principal executive offices located?
The principal executive offices are located at Ole Maaløes Vej 3, DK-2200 Copenhagen N, Denmark.
What is the state of incorporation for IO Biotech, Inc.?
IO Biotech, Inc. is incorporated in Delaware.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Filing Stats: 549 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2025-11-18 06:30:19
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share IOBT The Nasdaq Stock Mar
Filing Documents
- d59895d8k.htm (8-K) — 25KB
- d59895dex991.htm (EX-99.1) — 36KB
- g59895ex99_1s10g1.jpg (GRAPHIC) — 81KB
- g59895ex99_1s11g1.jpg (GRAPHIC) — 143KB
- g59895ex99_1s12g1.jpg (GRAPHIC) — 112KB
- g59895ex99_1s13g1.jpg (GRAPHIC) — 150KB
- g59895ex99_1s14g1.jpg (GRAPHIC) — 127KB
- g59895ex99_1s15g1.jpg (GRAPHIC) — 54KB
- g59895ex99_1s16g1.jpg (GRAPHIC) — 115KB
- g59895ex99_1s17g1.jpg (GRAPHIC) — 113KB
- g59895ex99_1s18g1.jpg (GRAPHIC) — 93KB
- g59895ex99_1s19g1.jpg (GRAPHIC) — 115KB
- g59895ex99_1s1g1.jpg (GRAPHIC) — 60KB
- g59895ex99_1s20g1.jpg (GRAPHIC) — 109KB
- g59895ex99_1s21g1.jpg (GRAPHIC) — 45KB
- g59895ex99_1s22g1.jpg (GRAPHIC) — 109KB
- g59895ex99_1s23g1.jpg (GRAPHIC) — 105KB
- g59895ex99_1s24g1.jpg (GRAPHIC) — 42KB
- g59895ex99_1s25g1.jpg (GRAPHIC) — 118KB
- g59895ex99_1s26g1.jpg (GRAPHIC) — 45KB
- g59895ex99_1s27g1.jpg (GRAPHIC) — 97KB
- g59895ex99_1s28g1.jpg (GRAPHIC) — 98KB
- g59895ex99_1s2g1.jpg (GRAPHIC) — 143KB
- g59895ex99_1s3g1.jpg (GRAPHIC) — 58KB
- g59895ex99_1s4g1.jpg (GRAPHIC) — 146KB
- g59895ex99_1s5g1.jpg (GRAPHIC) — 117KB
- g59895ex99_1s6g1.jpg (GRAPHIC) — 52KB
- g59895ex99_1s7g1.jpg (GRAPHIC) — 108KB
- g59895ex99_1s8g1.jpg (GRAPHIC) — 127KB
- g59895ex99_1s9g1.jpg (GRAPHIC) — 74KB
- 0001193125-25-285282.txt ( ) — 3989KB
- iobt-20251118.xsd (EX-101.SCH) — 3KB
- iobt-20251118_lab.xml (EX-101.LAB) — 17KB
- iobt-20251118_pre.xml (EX-101.PRE) — 11KB
- d59895d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 99.1 IO Biotech, Inc., Investor Deck, dated as of November 18, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IO BIOTECH, INC. Date: November 18, 2025 By: /s/ Mai-Britt Zocca, Ph.D. Name: Mai-Britt Zocca, Ph.D. Title: Chief Executive Officer